HomeComparePKI vs CVX

PKI vs CVX: Dividend Comparison 2026

PKI yields 0.24% · CVX yields 3.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVX wins by $29.5K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
CVX
Chevron Corporation
● Live price
3.28%
Share price
$210.76
Annual div
$6.91
5Y div CAGR
24.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.2K
Annual income
$4,937.38
Full CVX calculator →

Portfolio growth — PKI vs CVX

📍 CVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKICVX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + CVX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
CVX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
CVX
Annual income on $10K today (after 15% tax)
$278.68/yr
After 10yr DRIP, annual income (after tax)
$4,196.77/yr
At 15% tax rate, CVX beats the other by $4,196.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + CVX for your $10,000?

PKI: 50%CVX: 50%
100% CVX50/50100% PKI
Portfolio after 10yr
$34.5K
Annual income
$2,468.70/yr
Blended yield
7.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CVX right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
CVX
Analyst Ratings
32
Buy
16
Hold
4
Sell
Consensus: Buy
Price Target
$184.54
-12.4% upside vs current
Range: $160.00 — $212.00
Altman Z
3.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
CVX buys
0
No recent congressional trades found for PKI or CVX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKICVX
Forward yield0.24%3.28%
Annual dividend / share$0.28$6.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%24.1%
Portfolio after 10y$19.7K$49.2K
Annual income after 10y$0.02$4,937.38
Total dividends collected$24.00$18.4K
Payment frequencyquarterlyquarterly
SectorStockEnergy
Analyst consensusHoldBuy
Analyst price target$166.57$184.54

Year-by-year: PKI vs CVX ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrCVX PortfolioCVX Income/yrGap
1← crossover$10,712$12.15$11,387$406.88$675.00CVX
2$11,468$6.08$13,026$523.64$1.6KCVX
3$12,274$3.04$14,980$677.06$2.7KCVX
4$13,135$1.52$17,328$880.00$4.2KCVX
5$14,055$0.76$20,177$1,150.51$6.1KCVX
6$15,039$0.38$23,668$1,514.12$8.6KCVX
7$16,092$0.19$27,995$2,007.45$11.9KCVX
8$17,218$0.10$33,422$2,683.68$16.2KCVX
9$18,424$0.05$40,319$3,621.22$21.9KCVX
10$19,713$0.02$49,208$4,937.38$29.5KCVX

PKI vs CVX: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

CVXEnergy

Chevron Corporation, through its subsidiaries, engages in integrated energy and chemicals operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant. The Downstream segment engages in refining crude oil into petroleum products; marketing crude oil, refined products, and lubricants; manufacturing and marketing of renewable fuels; transporting crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car; and manufacturing and marketing of commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives. It is also involved in the cash management and debt financing activities; insurance operations; real estate activities; and technology businesses. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is based in San Ramon, California.

Full CVX Calculator →
📬

Get this PKI vs CVX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAINPKI vs XOMPKI vs COPPKI vs OXY

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.